Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Allogene Therapeutics Partners With Foresight Diagnostics To Develop MRD-Based In-Vitro Diagnostic For Use In ALPHA3, For Frontline Consolidation In Large B-Cell Lymphoma

Author: Benzinga Newsdesk | January 04, 2024 05:18pm

Partnership Will Utilize Foresight's Ultra-Sensitive MRD Technology to Identify Patients for Enrollment in Allogene's ALPHA3 Trial

Posted In: ALLO